[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intracerebral-hemorrhage-ich\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intracerebral-hemorrhage-ich":61},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100627147",false,"NCT07444853","Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers","TIPITCH","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment;\n* Obtaining non-opposition\n\nExclusion Criteria:\n\n* First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting);\n* Intracerebral hemorrhage secondary to another identified condition, including:\n\n  * vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.);\n  * intracranial tumor;\n  * hemorrhagic transformation of a cerebral infarction;\n  * recent head trauma.\n* Patient under legal protection;\n* Patient under guardianship or conservatorship.","ALL","18 Years",{"count":18,"type":19},10000,"ESTIMATED","2 Years","OBSERVATIONAL","This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.\n\nThe study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.\n\nThe cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.",[24],"Intracerebral Hemorrhage (ICH)",[26],"diagnostic and prognostic biomarkers","RECRUITING","2026-04-29",{"date":30,"type":31},"2026-05-06","ACTUAL",{"date":33,"type":31},"2026-04-09",{"date":35,"type":19},"2036-04",{"name":37,"class":38},"University Hospital, Tours","OTHER",4,{"id":41,"slug":4,"hasResults":10,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":46,"targetDuration":48,"studyType":21,"phases":4,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":4},"100600641","NCT07100132","Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients","Research on the Clinical Value of Cranial CT and CTA in Patients With Cerebral Hemorrhage","Inclusion Criteria:\n\n(1) Patients who were confirmed to have cerebral hemorrhage through head CT imaging examination upon admission; (2) Those who completed head CT and CTA within 8 hours of onset and had a follow-up CT within 24 hours of admission; (3) With complete clinical data.\n\nExclusion Criteria:\n\n(1) Patients who cannot complete CT and CTA within the prescribed time; (2) Patients with secondary cerebral hemorrhage due to cerebral vascular malformations, brain tumors, brain trauma, cerebral aneurysms, etc.; (3) Patients who have been taking oral anticoagulants for a long time or have blood system diseases; (4) Primary intraventricular hemorrhage.",{"count":47,"type":19},300,"6 Months","The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.",[24],"NOT_YET_RECRUITING","2025-07-27",{"date":54,"type":31},"2025-08-03",{"date":56,"type":19},"2025-10-01",{"date":58,"type":19},"2027-06-01",{"name":60,"class":38},"The Affiliated Hospital Of Guizhou Medical University",""]